An industrial brawl could be brewing at GlaxoSmithKline. Hundreds of GSK employees in the U.K. have voted to strike against a “derisory” pay raise offer from the British Big Pharma, local labor union ...
UK pharma major GSK (LSE: GSK) has set out full survival data for risvutatug rezetecan, its B7-H3 targeted antibody-drug ...
GSK has averted an industrial kerfuffle in the United Kingdom. A potential strike by more than 1,000 GSK engineers, technicians, laboratory analysts, warehouse workers and others has been called off ...
UK pharma major GSK today announced it has entered an agreement to acquire a potential best-in-class trispecific T ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The FINANCIAL — GSK on April 18 opens a £56 million state of the art manufacturing facility, creating 150 new jobs in the UK, in response to demand for GSK’s portfolio of respiratory medicines ...
GSK is collaborating with the UK Dementia Research Institute (UK DRI) and Health Data Research UK (HDR UK) to investigate whether GSK's shingles vaccine, Shingrix (zoster vaccine recombinant), could ...
Pfizer Inc (NYSE:PFE) has reportedly secured a major contract with the U.K. to supply millions of doses of its Abrysvo respiratory syncytial virus (RSV) vaccine, edging out local pharmaceutical giant ...
Shares of the UK-based GlaxoSmithKline PLC (GB:GSK) fell by 2.07% yesterday despite the company upgrading its full-year guidance after achieving strong sales for HIV and cancer drugs in the second ...
GSK Plc (NYSE:GSK) has received UK approval for its oral antibiotic Blujepa (gepotidacin), designed to treat uncomplicated urinary tract infections. According to the UK medicines regulator, UTIs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results